Elite BioPharma Consulting

What Elite BioPharma Consulting does

Elite BioPharma Consulting is a private, Boston-based professional services firm founded in 2019 that provides clinical development and operational leadership consulting to pharmaceutical, biotechnology, and medical device companies. The firm covers the full lifecycle of drug and device development, from initial application through final filing, and offers strategic resourcing, clinical program oversight, CRO management, and infrastructure-building support for sponsors seeking to run trials independently, efficiently, and affordably. Its stated positioning is as a cost-efficient alternative to large Contract Research Organizations, particularly for small biotechs transitioning from research-stage to clinical-stage operations.

The business model is professional services, delivered through a small core team augmented by a curated network of trusted consultants matched to client capabilities and culture. Pricing is quote-based and not publicly disclosed, with direct client engagement driven via the company website and email. The firm claims 70-75+ years of combined clinical development experience across its co-founders, Jill C. Bossi (President and Co-Founder) and Shawna H. Evans (Co-Founder), with a reported third president-level leader, Connacht Peterson, also listed. To extend its service surface beyond pure clinical consulting, the firm maintains a strategic affiliation with Danforth Health, enabling integrated capabilities for clients.

Elite BioPharma does not disclose revenue, has no external funding rounds, holds no patents, and reports no AI/ML capabilities or proprietary technology platform. Marketing is primarily website-driven, and customer evidence is limited to two named testimonials: a Chief Medical Officer at a small biotech and a Director of Clinical Research at a Boston-based pharmaceutical company. The firm's geographic footprint is anchored in Boston, with self-described global industry experience across therapeutic areas.

Name

Elite BioPharma Consulting

Legal name

Elite BioPharma Consulting

Website

https://elitebpconsulting.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Elite BioPharma Consulting is a Boston-based, private clinical development and operational leadership consulting firm founded in 2019, serving pharmaceutical, biotechnology, and medical device companies as a cost-efficient alternative to large CROs.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Biotech Consulting

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Life Sciences & Biotech (R&D/Clinical) Staffing (BPACADAL)

Keywords

• Clinical development consulting
• Biopharma operational leadership
• Drug development advisory
• Clinical trial resourcing
• Biotech consulting services

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Clinical Development Consulting: Professional consulting services for pharmaceutical, biotech and device companies covering all stages of drug development from initial application through final filing. Services include strategic support, operational execution, and resourcing across clinical development functions.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Elite BioPharma Consulting provides clinical development and operational leadership consulting services to pharmaceutical, biotech, and device companies. The firm delivers customized consulting support across all phases of drug and device development—from initial application through final filing—offering strategic resourcing, operational execution, and the building of clinical trial infrastructure as a cost-efficient alternative to CROs.

Product overview

Elite BioPharma Consulting is a consulting firm that provides clinical development and operational leadership consulting services to pharmaceutical, biotech, and device companies. Based in Boston, MA, the company offers customized consulting support across all phases of drug and device development, from initial application through final filing. Their services include strategic resourcing across clinical development functions, helping clients build and streamline infrastructure to run clinical trials independently, efficiently, and affordably. The company differentiates itself by eliminating the need for costly CROs (Contract Research Organizations) and strategically matching clients with consultants from their trusted network based on capabilities and culture fit.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Development & Operational Leadership Consulting Customized consulting support covering all stages of drug and device development—from initial application through final filing—including strategic resourcing across clinical development functions, operational execution, and building/streamlining of trial infrastructure for clients. Targeted at pharmaceutical, biotech, and medical device companies seeking to run clinical programs independently without incurring CRO costs.

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Danforth HealthcoreStrategic or Co-development PartnerElite BioPharma Consulting offers integrated capabilities through affiliation with Danforth Health. This partnership allows them to offer additional integrated services beyond their core clinical development consulting, expanding their service offerings to clients.

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Medpace: Mid-to-large CRO focused on full-service clinical development for emerging and mid-sized biotechs—directly overlapping Elite's target customer base of small biotech companies needing outsourced clinical expertise.
• Charles River Laboratories: Large CRO/CDMO providing clinical development, regulatory, and consulting services to pharma and biotech, including small/mid biotechs that are Elite's primary buyers.
• Parexel International: Large global CRO with full clinical development (Phase I–IV) and consulting services for pharma and biotech. Competes for the same clinical development and operational leadership engagements Elite BioPharma pursues, but at vastly greater scale.
• ICON plc: Top-tier global CRO offering clinical development, biostatistics, and consulting services across all therapeutic areas. Competes head-to-head with Elite for sponsor clinical programs while offering global scale Elite cannot match.
• Worldwide Clinical Trials: Mid-sized global CRO offering clinical operations, biostatistics, and consulting for biotech and pharma, including boutique-style service for emerging sponsors—comparable to Elite's clinical development consulting focus.
• Synteract (now part of Q² Solutions): Mid-tier CRO with explicit focus on emerging biotech and mid-market pharma, offering clinical development and operational services—overlapping the small-biotech segment Elite serves.
• Catalent (now part of Novo Holdings): Large CDMO/CRO with clinical development and consulting capabilities, particularly strong with smaller biotech sponsors needing integrated development support—comparable buyer segment to Elite's.

Direct peers

• BluePrint Research Group: Boutique clinical development and regulatory strategy consulting firm serving biotech and pharma—similar in scale, service mix, and client base to Elite BioPharma Consulting.
• Allucent: Clinical research and consulting organization purpose-built for small and mid-sized biotechs, offering clinical operations and regulatory support—directly comparable to Elite's positioning as a cost-efficient alternative to large CROs.
• The Weinberg Group: Boutique life-sciences consulting firm offering regulatory, clinical development, and product strategy support to pharma and biotech—most similar in business model and customer base to Elite BioPharma Consulting.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/elite-biopharma-consulting-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elite BioPharma Consulting